[1] [1] A. A. Forastiere, A. Trotti, D. G. Pfister, J. R. Grandis, "Head and neck cancer: Recent advances and new standards of care," J. Clin. Oncol. 24, 2603-2605 (2006).

[2] [2] M. Goerner, T. Y. Seiwert, H. Sudhoff, "Molecular targeted therapies in head and neck cancer — An update of recent developments," Head Neck Oncol. 2, 8 (2010).

[3] [3] A. Jemal, R. Siegel, J. Xu, E. Ward, "Cancer statistics, 2010,"CACancer J. Clin. 60, 277-300 (2010).

[4] [4] "Head and Neck Cancer," National Cancer Institute at the National Institutes of Health, Available at http://www.cancer.gov/cancertopics/factsheet/ Sites-Types/head-and-neck, 17 April (2012).

[5] [5] R. Siegel, D. Naishadham, A. Jemal, "Cancer statistics, 2012," CA Cancer J. Clin. 62, 10-29 (2012).

[6] [6] D. Sano, J. N. Myers, "Xenograft models of head and neck cancers," Head Neck Oncol. 1, 32 (2009).

[7] [7] P. Ray, A. De, "Reporter gene imaging in therapy and diagnosis," Theranostics 2, 333-334 (2012).

[8] [8] P. Dubey, "Reporter gene imaging of immune responses to cancer: Progress and challenges," Theranostics 2, 355-362 (2012).

[9] [9] I. Serganova, P. Mayer-Kukuck, R. Huang, R. Blasberg, "Molecular imaging:Reporter gene imaging," Handbook Exp. Pharmacol. 185 pt 2, 167-223 (2008).

[10] [10] J. H. Kang, J. K. Chung, "Molecular-genetic imaging based on reporter gene expression," J. Nucl. Med. 49(2), 164S-179S (2008).

[11] [11] T. Imamura, A. Hanyu, A. Hikita, "In vivo optical imaging of cancer," Seikagaku 83, 406-409 (2011).

[12] [12] K. O'Neill, S. K. Lyons, W. M. Gallagher, K. M. Curran, A. T. Byrne, "Bioluminescent imaging: A critical tool in pre-clinical oncology research," J. Pathol. 220, 317-327 (2010).

[13] [13] T. F. Massoud, S. S. Gambhir, "Molecular imaging in living subjects: Seeing fundamental biological processes in a new light," Genes Dev. 17, 545-580 (2003).

[14] [14] P. Mayer-Kuckuk, L. G. Menon, R. G. Blasberg, J. R. Bertino, D. Banerjee, "Role of reporter gene imaging in molecular and cellular biology," Biol. Chem. 385, 353-361 (2004).

[15] [15] I. Serganova, R. Blasberg, "Reporter gene imaging: Potential impact on therapy," Nucl. Med. Biol. 32, 763-780 (2005).

[16] [16] T. Boulin, J. F. Etchberger, O. Hobert, H. Hughes, "Reporter gene fusions," WormBook, ed. The C. elegans Research Community, pp. 1-23 (2006).

[17] [17] P. Ray, R. Tsien, S. S. Gambhir, "Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects," Cancer Res. 67, 3085-3093 (2007).

[18] [18] Y. J. Kim, P. Dubey, P. Ray, S. S. Gambhir, O. N. Witte, "Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a trifusion reporter gene," Molec. ImagingBiol. 6, 331-340 (2004).

[19] [19] P. Ray, A. De, J. J. Min, R. Y. Tsien, S. S. Gambhir, "Imaging tri-fusion multimodality reporter gene expression in living subjects," Cancer Res. 64, 1323-1330 (2004).

[20] [20] D. Shcherbo, E. M. Merzlyak, T. V. Chepurnykh, A. F. Fradkov, G. V. Ermakova, E. A. Solovieva, K. A. Lukyanov, E. A. Bogdanova, A. G. Zaraisky, S. Lukyanov, D. M. Chudakov, "Bright far-red fluorescent protein for whole-body imaging," Natl.Methods 4, 741-746 (2007).

[21] [21] J. Chu, Z. Zhang, Y. Zheng, J. Yang, L. Qin, J. Lu, Z. L. Huang, S. Zeng, Q. Luo, "A novel far-red bimolecular fluorescence complementation system that allows for efficient visualization of protein interactions under physiological conditions," Biosens. Bioelectron. 25, 234-239 (2009).

[22] [22] X. Yang, H. Gong, J. Fu, G. Quan, C. Huang, Q. Luo, "Molecular imaging of small animals with fluorescent proteins: Fromprojection tomultimodality," Comput. Med. Imaging Graph. 36, 259-263 (2012).

[23] [23] W. Van den Broeck, A. Derore, P. Simoens, "Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice," J. Immunol. Methods 312, 12-19 (2006).

[24] [24] T. Liu, Y. Ding, W. Xie, Z. Li, X. Bai, X. Li, W. Fang, C. Ren, S. Wang, R. M. Hoffman, K. Yao, "An imageable metastatic treatment model of nasopharyngeal carcinoma," Clin. Cancer Res. 13, 3960-3967 (2007).

[25] [25] J. D. Mocanu, E. H. Moriyama, M. C. Chia, J. H. Li, K. W. Yip, D. P. Huang, C. Bastianutto, B. C. Wilson, F. F. Liu, "Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy," Molec. Imaging 3, 352-355 (2004).

[26] [26] S. Walenta, T. Schroeder, W. Mueller-Klieser, "Metabolic mapping with bioluminescence: Basic and clinical relevance," Biomol. Engrg. 18, 249-262 (2002).

[27] [27] P. Tamulevicius, C. Streffer, "Metabolic imaging in tumours by means of bioluminescence," Br. J. Cancer 72, 1102-1112 (1995).

[28] [28] D. M. Brizel, T. Schroeder, R. L. Scher, S. Walenta, R. W. Clough, M. W. Dewhirst, W. Mueller-Klieser, "Elevated tumor lactate concentrations predict for an increased risk ofmetastases in head-and-neck cancer," Int. J. Radiat. Oncol. Biol. Phys. 51, 349-353 (2001).

[29] [29] J. H. Law, A. S. Whigham, P. S. Wirth, D. Liu, M. Q. Pham, S. Vadivelu, K. C. Kirkbride, B. T. Brown, B. B. Burkey, R. J. Sinard, J. L. Netterville, W. G. Yarbrough, "Human-in-mouse modeling of primary head and neck squamous cell carcinoma," Laryngoscope 119, 2315-2323 (2009).

[30] [30] B. A. Neff, S. G. Voss, C. Allen, M. A. Schroeder, C. L. Driscoll, M. J. Link, E. Galanis, J. N. Sarkaria, "Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice," Otol. Neurotol. 30, 105-111 (2009).

[31] [31] T. Nakatsu, S. Ichiyama, J. Hiratake, A. Saldanha, N. Kobashi, K. Sakata, H. Kato, "Structural basis for the spectral difference in luciferase bioluminescence," Nature 440, 372-376 (2006).

[32] [32] R. Dieguez-Hurtado, J. Martin, I. Martinez-Corral, M. D. Martinez, D. Megias, D. Olmeda, S. Ortega, "A Cre-reporter transgenic mouse expressing the far-red fluorescent protein Katushka," Genesis 49, 36-45 (2011).